
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
Yan Lv, Xiao Ma, Yuxin Ma, et al.
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2366-2382
Open Access | Times Cited: 68
Yan Lv, Xiao Ma, Yuxin Ma, et al.
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2366-2382
Open Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Natalia Sauer, Natalia Janicka, Wojciech Szlasa, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3405-3425
Open Access | Times Cited: 65
Natalia Sauer, Natalia Janicka, Wojciech Szlasa, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3405-3425
Open Access | Times Cited: 65
LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation
Nicole Joller, Ana C. Anderson, Vijay K. Kuchroo
Immunity (2024) Vol. 57, Iss. 2, pp. 206-222
Open Access | Times Cited: 52
Nicole Joller, Ana C. Anderson, Vijay K. Kuchroo
Immunity (2024) Vol. 57, Iss. 2, pp. 206-222
Open Access | Times Cited: 52
Differential impact of TIM-3 ligands on NK cell function
Juncheng Wang, Housaiyin Li, Aditi Kulkarni, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010618-e010618
Open Access | Times Cited: 2
Juncheng Wang, Housaiyin Li, Aditi Kulkarni, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010618-e010618
Open Access | Times Cited: 2
Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules
Ali Hazrati, Kosar Malekpour, Hossein Khorramdelazad, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Ali Hazrati, Kosar Malekpour, Hossein Khorramdelazad, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy
Doménica Tarallo, Jennyfer Martínez, Alejandro Leyva, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Doménica Tarallo, Jennyfer Martínez, Alejandro Leyva, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
Zeynep Akbulut, Başak Aru, Furkan Aydın, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Zeynep Akbulut, Başak Aru, Furkan Aydın, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Molecular and cellular morphology of placenta unveils new mechanisms of reproductive immunology
Penghao Li, Liting Zeng, Xiaomiao Yan, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Penghao Li, Liting Zeng, Xiaomiao Yan, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies
Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli
Cancers (2025) Vol. 17, Iss. 5, pp. 906-906
Open Access | Times Cited: 1
Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli
Cancers (2025) Vol. 17, Iss. 5, pp. 906-906
Open Access | Times Cited: 1
Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5
Single‐cell characterization of differentiation trajectories and drug resistance features in gastric cancer with peritoneal metastasis
Haoxin Peng, Lei Jiang, Jiajia Yuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 4
Haoxin Peng, Lei Jiang, Jiajia Yuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 4
Enhancement of adipose stem cell quality via Cu‐MON : Transcriptome and bioinformatics analysis of normal and diabetic stem cells
Richong Pang, K. Liu, Biou Liu, et al.
FASEB BioAdvances (2025)
Open Access
Richong Pang, K. Liu, Biou Liu, et al.
FASEB BioAdvances (2025)
Open Access
Study of immunosenescence in the occurrence and immunotherapy of gastrointestinal malignancies
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Dissecting the Spatial and Single‐Cell Transcriptomic Architecture of Cancer Stem Cell Niche Driving Tumor Progression in Gastric Cancer
Guangyu Zhang, Xin Zhang, Wenting Pan, et al.
Advanced Science (2025)
Open Access
Guangyu Zhang, Xin Zhang, Wenting Pan, et al.
Advanced Science (2025)
Open Access
Expression of co-signaling molecules TIM-3/Galectin-9 at the maternal-fetal interface
Jingliang Xu, Xuqing He, Sujuan Zhang, et al.
Placenta (2025) Vol. 163, pp. 43-50
Open Access
Jingliang Xu, Xuqing He, Sujuan Zhang, et al.
Placenta (2025) Vol. 163, pp. 43-50
Open Access
Transcriptome combined with single-cell sequencing explored prognostic markers associated with T cell exhaustion characteristics in head and neck squamous carcinoma
Jie Liu, Penghui Li, Yuanyuan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Jie Liu, Penghui Li, Yuanyuan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
An In‐Silico Study to Identify Relevant Biomarkers in Sepsis Applying Integrated Bulk RNA Sequencing and Single‐Cell RNA Sequencing Analyses
Qile Ye, Yuhang Dong, Jingting Liang, et al.
Global Challenges (2025) Vol. 9, Iss. 4
Open Access
Qile Ye, Yuhang Dong, Jingting Liang, et al.
Global Challenges (2025) Vol. 9, Iss. 4
Open Access
Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia
Caroline R.M. Wiggers, Burak Yüzügüldü, Nathanial G. Tadros, et al.
Science Advances (2025) Vol. 11, Iss. 12
Closed Access
Caroline R.M. Wiggers, Burak Yüzügüldü, Nathanial G. Tadros, et al.
Science Advances (2025) Vol. 11, Iss. 12
Closed Access
Multifaceted roles of Galectins: from carbohydrate binding to targeted cancer therapy
Nan Zhang, Qiao Liu, Dan Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Nan Zhang, Qiao Liu, Dan Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Galectin-9 induces IL-1β production as a key inflammatory cytokine in the acute myeloid leukemia cell line (U937)
Nafiseh Behranvand, Farzad Nasri, Minoo J. Moghaddam, et al.
Research in Pharmaceutical Sciences (2025) Vol. 20, Iss. 2, pp. 304-315
Open Access
Nafiseh Behranvand, Farzad Nasri, Minoo J. Moghaddam, et al.
Research in Pharmaceutical Sciences (2025) Vol. 20, Iss. 2, pp. 304-315
Open Access
Development of a breast cancer invasion score to predict tumor aggressiveness and prognosis via PI3K/AKT/mTOR pathway analysis
Xiujuan Li, Ya Zhang, Jianping Gong, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Xiujuan Li, Ya Zhang, Jianping Gong, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Endometrial Stromal Senescence Mediates the Progression of Intrauterine Adhesions
Pavel I. Deryabin, Aleksandra V. Borodkina
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4183-4183
Open Access
Pavel I. Deryabin, Aleksandra V. Borodkina
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4183-4183
Open Access
Galectin inhibitors and nanoparticles as a novel therapeutic strategy for glioblastoma multiforme
Willie Elliott
American Journal of Cancer Research (2024) Vol. 14, Iss. 2, pp. 774-795
Open Access | Times Cited: 3
Willie Elliott
American Journal of Cancer Research (2024) Vol. 14, Iss. 2, pp. 774-795
Open Access | Times Cited: 3
Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection
I. Righi, Daria Trabattoni, Lorenzo Rosso, et al.
Immunology Letters (2024) Vol. 267, pp. 106860-106860
Open Access | Times Cited: 3
I. Righi, Daria Trabattoni, Lorenzo Rosso, et al.
Immunology Letters (2024) Vol. 267, pp. 106860-106860
Open Access | Times Cited: 3
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target
Cèlia Dobaño-López, Juan García Valero, Ferran Araujo‐Ayala, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Cèlia Dobaño-López, Juan García Valero, Ferran Araujo‐Ayala, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms
Santhasiri Orrapin, Sutpirat Moonmuang, Sasimol Udomruk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Santhasiri Orrapin, Sutpirat Moonmuang, Sasimol Udomruk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3